Hydromorphone and naloxone for treatment of pain and opioid bowel dysfunction syndrome
US10258616B2 · kind B2 · utility
0Cited by
49References
18Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Nov 10, 2017 |
| Grant date | Apr 16, 2019 |
| Priority date | — |
| Expiry date | Nov 10, 2037 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P43/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to prolonged release pharmaceutical dosage forms comprising hydromorphone or a pharmaceutically acceptable salt thereof and naloxone or a pharmaceutically acceptable salt thereof for use in the treatment of pain.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.